Early Assessment by FDG-PET/CT of Patients with Advanced Renal Cell Carcinoma Treated with Tyrosine Kinase Inhibitors is Predictive of Disease Course

BMC Cancer, 05/04/2012

The evaluation of renal cell carcinoma (RCC) response to tyrosine kinase inhibitors (TKIs) by tumor size and FDG uptake using 18F–2–fluoro–2–deoxyglucose positron emission tomography/ computed tomography (FDG PET/CT) after 1month can predict progression free survival (PFS) and overall survival (OS).

Print Article Summary Cat 2 CME Report